Menu

• Ask a Health Expert about CENTRAL LINE INFECTION
• Post Your Side Effect related to CENTRAL LINE INFECTION
• CENTRAL LINE INFECTION and FDA Warnings
• CENTRAL LINE INFECTION in Patients Wiki
• Report CENTRAL LINE INFECTION in Drug Side Effect Survey

CENTRAL LINE INFECTION side effect

What is CENTRAL LINE INFECTION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Fabrazyme Side Effects Report #5664328-X
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Mar 03, 2008. Male patient, 35 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, urinary tract obstruction, . FABRAZYME dosage: 1 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Humira Side Effects Report #5666879-0
HUMIRA problem was reported by a Health Professional from UNITED STATES on Jan 02, 2008. Female patient, 47 years of age, was diagnosed with crohn's disease and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: central line infection, injection site pain, . HUMIRA dosage: unknown. Patient recovered.

Tysabri Side Effects Report #5671025-3
Health Professional from UNITED STATES reported TYSABRI problem on Mar 06, 2008. Female patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: central line infection, gastric ulcer, obstruction gastric, post procedural infection, staphylococcal sepsis, upper gastrointestinal haemorrhage, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.

Ibandronic Side Effects Report #5674217-2
IBANDRONIC ACID problem was reported by a Physician from GERMANY on Mar 13, 2008. Male patient, 38 years of age, weighting 154.3 lb, was treated with IBANDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: central line infection, ill-defined disorder, . IBANDRONIC ACID dosage: unknown. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.


Flolan Side Effects Report #5682837-4
Consumer or non-health professional from UNITED STATES reported FLOLAN problem on Mar 19, 2008. Female patient, 50 years of age, was treated with FLOLAN. After drug was administered, patient experienced the following problems/side effects: central line infection, vision blurred, visual disturbance, . FLOLAN dosage: unknown. During the same period patient was treated with STARLIX, SYNTHROID, CEFTIN. Patient was hospitalized. Patient recovered.

Aranesp Side Effects Report #5630474-X
ARANESP problem was reported by a Health Professional from AUSTRALIA on Feb 06, 2008. Male patient, weighting 165.3 lb, was diagnosed with dialysis, renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: central line infection, haemoglobin increased, lymphopenia, neutrophilia, . ARANESP dosage: unknown. During the same period patient was treated with OMEPRAZOLE, CALTRATE, CALCITRIOL, MYLANTA, SENSIPAR. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5635847-7
Physician from JAPAN reported PROGRAF problem on Feb 08, 2008. Female patient, 26 years of age, weighting 92.59 lb, was diagnosed with small intestine transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: central line infection, dehydration, electrolyte imbalance, renal impairment, sepsis, small intestinal stenosis, transplant rejection, . PROGRAF dosage: unknown. During the same period patient was treated with MEDROL, ROHYPNOL, MARZULENE S, LANSOPRAZOLE. Patient recovered.

Heparin Side Effects Report #5581603-8
HEPARIN LOCK problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 03, 2008. Female patient, weighting 120.0 lb, was diagnosed with localised infection and was treated with HEPARIN LOCK. After drug was administered, patient experienced the following problems/side effects: central line infection, chills, colitis ischaemic, malaise, pollakiuria, pyrexia, . HEPARIN LOCK dosage: 5 ML IN 12 ML SYRINGE 1 X DAILY. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5607400-2
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Jan 15, 2008. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: central line infection, fall, foot fracture, localised infection, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.


Aciphex Side Effects Report #5578751-5
ACIPHEX problem was reported by a Physician from UNITED STATES on Dec 13, 2007. Female patient, 76 years of age, weighting 183.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with ACIPHEX. After drug was administered, patient experienced the following problems/side effects: central line infection, colitis ischaemic, sepsis, . ACIPHEX dosage: 20 MG, ORAL. During the same period patient was treated with LIDICAIN VISCOUS, SERTRALINE, ASPIRIN, FLAGIL, CIPRO, ACETAMINOPHEN, DARVOCIT, LANTUS. Patient was hospitalized. Patient died on 11/20/2007.

Aciphex Side Effects Report #5579313-6
Physician from UNITED STATES reported ACIPHEX problem on Dec 13, 2007. Female patient, 76 years of age, weighting 183.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with ACIPHEX. After drug was administered, patient experienced the following problems/side effects: central line infection, colitis ischaemic, renal failure chronic, sepsis, . ACIPHEX dosage: 20 MG, ORAL. During the same period patient was treated with LIDOCAINE VISCOUS, SERTRALINE, ASPIRIN, PLAXIC, FLAGIL, CIPRO, ACETAMINOPHEN, DARVOCIT. Patient was hospitalized. Patient died on 11/20/2007.

Intralipid Side Effects Report #5517736-1
INTRALIPID problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Male patient was diagnosed with parenteral nutrition and was treated with INTRALIPID. After drug was administered, patient experienced the following problems/side effects: central line infection, device failure, staphylococcal infection, . INTRALIPID dosage: unknown. Patient recovered.

Cytarabine Side Effects Report #5534135-7
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Nov 29, 2007. Male patient, weighting 158.7 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: central line infection, pseudomonas infection, staphylococcal infection, . CYTARABINE dosage: 28800 MG. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.

Cytarabine Side Effects Report #5534137-0
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2007. Male patient, weighting 158.7 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: central line infection, pseudomonas infection, staphylococcal infection, . CYTARABINE dosage: 28800 MG. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.


Neupogen Side Effects Report #5478025-7
Health Professional from FRANCE reported NEUPOGEN problem on Sept 24, 2007. Male patient, 45 years of age, was diagnosed with neutropenia and was treated with NEUPOGEN. After drug was administered, patient experienced the following problems/side effects: central line infection, dermatitis exfoliative, dysphagia, enterococcal infection, escherichia bacteraemia, lymphangitis, metabolic acidosis, pyrexia, rash scarlatiniform, . NEUPOGEN dosage: unknown. During the same period patient was treated with TARGOCID, VALGANCICLOVIR, KIVEXA, NORVIR, SUSTIVA, PREZISTA, IMOVANE, LEXOMIL. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5494234-5
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2007. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: central line infection, fall, foot fracture, localised infection, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Forteo Side Effects Report #5448541-2
Consumer or non-health professional from UNITED STATES reported FORTEO problem on Sept 04, 2007. Female patient was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: central line infection, dehydration, septic shock, . FORTEO dosage: unknown. Patient was hospitalized. Patient died on 04/28/2007.

Cytarabine Side Effects Report #5456215-7
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2007. Male patient, weighting 190.0 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: central line infection, deep vein thrombosis, platelet count decreased, . CYTARABINE dosage: unknown. Patient was hospitalized. Patient recovered.

Cytarabine Side Effects Report #5456763-X
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Sept 17, 2007. Male patient, weighting 190.0 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: central line infection, deep vein thrombosis, platelet count decreased, . CYTARABINE dosage: unknown. Patient was hospitalized. Patient recovered.


Avonex Side Effects Report #5463661-4
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2007. Male patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: central line infection, grand mal convulsion, renal failure, yellow skin, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Tygacil Side Effects Report #5421022-8
Physician from UNITED STATES reported TYGACIL problem on Aug 14, 2007. Female patient, weighting 185.2 lb, was diagnosed with abdominal abscess, sepsis and was treated with TYGACIL. After drug was administered, patient experienced the following problems/side effects: central line infection, staphylococcal infection, . TYGACIL dosage: unknown. During the same period patient was treated with DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.

Fluorouracil Side Effects Report #5385120-X
FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2007. Female patient, weighting 134.9 lb, was diagnosed with pancreatic carcinoma and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: central line infection, . FLUOROURACIL dosage: 2400 MG/M2 OVER 48 HRS IV AMBULATORY PUMP. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5390727-X
Health Professional from UNITED KINGDOM reported ALDURAZYME problem on Feb 22, 2006. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, . ALDURAZYME dosage: unknown. Patient recovered.

Aldurazyme Side Effects Report #5390956-5
ALDURAZYME problem was reported by a Health Professional from UNITED STATES on July 27, 2006. Female patient, weighting 18.54 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, human t-cell lymphotropic virus infection, . ALDURAZYME dosage: 11.6 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5390962-0
Health Professional from UNITED STATES reported ALDURAZYME problem on Apr 30, 2007. Female patient was diagnosed with mucopolysaccharidosis ih and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, lung neoplasm, staphylococcal sepsis, . ALDURAZYME dosage: 0.58 MG/MG QWK IV. Patient recovered.

Remodulin Side Effects Report #5403702-3
REMODULIN problem was reported by a Health Professional from UNITED STATES on May 08, 2007. Female patient, 45 years of age, weighting 163.1 lb, was diagnosed with pulmonary hypertension and was treated with REMODULIN. After drug was administered, patient experienced the following problems/side effects: central line infection, . REMODULIN dosage: unknown. During the same period patient was treated with OVCON, TRACLEER, WARFARIN, FLONASE. Patient was hospitalized. Patient recovered.

Remodulin Side Effects Report #5404787-0
Health Professional from UNITED STATES reported REMODULIN problem on Apr 19, 2007. Female patient, 36 years of age, weighting 154.3 lb, was diagnosed with pulmonary hypertension and was treated with REMODULIN. After drug was administered, patient experienced the following problems/side effects: central line infection, . REMODULIN dosage: unknown. During the same period patient was treated with SILDENAFIL CITRATE, LASIX, SPIRONOLACTONE, DIGOXIN, LOPERAMIDE, ONDANSETRON, ZOLPIDEM TARTRATE, LORTAB. Patient recovered.

Fluorouracil Side Effects Report #5385120-X
FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2007. Female patient, weighting 134.9 lb, was diagnosed with pancreatic carcinoma and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: central line infection, . FLUOROURACIL dosage: 2400 MG/M2 OVER 48 HRS IV AMBULATORY PUMP. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5390727-X
Health Professional from UNITED KINGDOM reported ALDURAZYME problem on Feb 22, 2006. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, . ALDURAZYME dosage: unknown. Patient recovered.

Aldurazyme Side Effects Report #5390956-5
ALDURAZYME problem was reported by a Health Professional from UNITED STATES on July 27, 2006. Female patient, weighting 18.54 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, human t-cell lymphotropic virus infection, . ALDURAZYME dosage: 11.6 MG Q2WKS IV. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5390962-0
Health Professional from UNITED STATES reported ALDURAZYME problem on Apr 30, 2007. Female patient was diagnosed with mucopolysaccharidosis ih and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, lung neoplasm, staphylococcal sepsis, . ALDURAZYME dosage: 0.58 MG/MG QWK IV. Patient recovered.

Remodulin Side Effects Report #5403702-3
REMODULIN problem was reported by a Health Professional from UNITED STATES on May 08, 2007. Female patient, 45 years of age, weighting 163.1 lb, was diagnosed with pulmonary hypertension and was treated with REMODULIN. After drug was administered, patient experienced the following problems/side effects: central line infection, . REMODULIN dosage: unknown. During the same period patient was treated with OVCON, TRACLEER, WARFARIN, FLONASE. Patient was hospitalized. Patient recovered.

Remodulin Side Effects Report #5404787-0
Health Professional from UNITED STATES reported REMODULIN problem on Apr 19, 2007. Female patient, 36 years of age, weighting 154.3 lb, was diagnosed with pulmonary hypertension and was treated with REMODULIN. After drug was administered, patient experienced the following problems/side effects: central line infection, . REMODULIN dosage: unknown. During the same period patient was treated with SILDENAFIL CITRATE, LASIX, SPIRONOLACTONE, DIGOXIN, LOPERAMIDE, ONDANSETRON, ZOLPIDEM TARTRATE, LORTAB. Patient recovered.

Enbrel Side Effects Report #5704874-3
ENBREL problem was reported by a Physician from UNITED STATES on Apr 03, 2008. Female patient, weighting 92.15 lb, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: central line infection, cerebrovascular spasm, cognitive disorder, decubitus ulcer, dysphagia, enterococcal infection, faecal incontinence, fluid overload, grand mal convulsion, . ENBREL dosage: unknown. During the same period patient was treated with CELEBREX, INSULIN, LANTUS. Patient was hospitalized. Patient recovered.

Flolan Side Effects Report #5345916-7
Consumer or non-health professional from UNITED STATES reported FLOLAN problem on May 31, 2007. Female patient, 40 years of age, weighting 194.0 lb, was treated with FLOLAN. After drug was administered, patient experienced the following problems/side effects: central line infection, medical device complication, . FLOLAN dosage: unknown. Patient recovered.

Cetuximab Side Effects Report #5361651-3
CETUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on June 15, 2007. Male patient, weighting 172.0 lb, was diagnosed with pancreatic carcinoma and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: central line infection, infusion site erythema, infusion site induration, infusion site pain, . CETUXIMAB dosage: 492MG IV. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, CLONAZEPAM, AVODART, NEXIUM, ZYRTEC, PAXIL. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5366668-0
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on June 06, 2007. Male patient, 22 years of age, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: central line infection, febrile neutropenia, hypotension, lung consolidation, oxygen saturation decreased, pleural effusion, pneumonia, . NOVANTRONE dosage: 16.7 MG, 1 IN 1 DAYS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.

Mitoxantrone Side Effects Report #5369645-9
MITOXANTRONE problem was reported by a Health Professional from UNITED STATES on June 14, 2007. Male patient, 22 years of age, was diagnosed with acute myeloid leukaemia and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: central line infection, condition aggravated, febrile neutropenia, hypotension, oxygen saturation decreased, pleural effusion, pneumonia, . MITOXANTRONE dosage: 16.7 MG QD IV. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Natalizumab Side Effects Report #5335588-X
Consumer or non-health professional from UNITED STATES reported NATALIZUMAB problem on May 11, 2007. Female patient, 25 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: central line infection, facial palsy, thrombosis, . NATALIZUMAB dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5293817-5
MYOZYME problem was reported by a Physician from ITALY on Mar 22, 2007. Female patient, weighting 14.33 lb, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, cyanosis, hypotension, infusion related reaction, oxygen saturation decreased, . MYOZYME dosage: 20 MG/KG Q2WKS IV. Patient recovered.

Abraxane Side Effects Report #5299141-9
Consumer or non-health professional from UNITED STATES reported ABRAXANE problem on Apr 11, 2007. Female patient, 55 years of age, was diagnosed with ovarian cancer recurrent and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: central line infection, chills, diarrhoea, pneumonia, staphylococcal bacteraemia, urinary tract infection, . ABRAXANE dosage: 518.0 MG EVERY 28 DAYS. During the same period patient was treated with CARBOPLATIN, ACETAMINOPHENLET, OXYCODONE, KETORLAC, LORAZEPAMECTION, ZOLPIDEM TARTLET, PROMETHAZINEECTION, DEXTROSE. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5299142-0
ABRAXANE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2007. Female patient, 55 years of age, was diagnosed with ovarian cancer recurrent and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: central line infection, . ABRAXANE dosage: 518.0MG EVERY 28 DAYS. During the same period patient was treated with CARBOPLATIN, WARFARIN, ESTRADIOL PATCH, FLAGYL, VANCOMYCIN, LORAZEPAM. Patient was hospitalized. Patient recovered.

Panitumumab Side Effects Report #5301251-4
Physician from UNITED KINGDOM reported PANITUMUMAB problem on Apr 04, 2007. Female patient, weighting 147.5 lb, was diagnosed with colorectal cancer and was treated with PANITUMUMAB. After drug was administered, patient experienced the following problems/side effects: central line infection, . PANITUMUMAB dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Estramustine Side Effects Report #5302913-5
ESTRAMUSTINE problem was reported by a Health Professional from UNITED STATES on Apr 19, 2007. Male patient, weighting 213.6 lb, was treated with ESTRAMUSTINE. After drug was administered, patient experienced the following problems/side effects: central line infection, enterobacter infection, . ESTRAMUSTINE dosage: 420 MG. During the same period patient was treated with VINBLASTINE SULPHATE, GLYBURIDE, NORVASC. Patient was hospitalized. Patient recovered.

Capecitabine Side Effects Report #5260864-9
Physician from UNITED STATES reported CAPECITABINE problem on Mar 01, 2007. Male patient, 61 years of age, weighting 250.0 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: central line infection, dehydration, diabetic ketoacidosis, staphylococcal sepsis, vomiting, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN, HYDROCHLOROTHIAZIDE, ASPIRIN, NITROGLYCERIN, TENORMIN, VASOTEC, TRICOR. Patient died on 10/15/2006.

Peginterferon Side Effects Report #5679740-2
PEGINTERFERON ALFA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 13, 2008. Male patient, child 12 years of age, weighting 55.12 lb, was diagnosed with metastases to lung and was treated with PEGINTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: arthritis bacterial, central line infection, device related infection, staphylococcal infection, . PEGINTERFERON ALFA dosage: unknown. Patient was hospitalized. Patient recovered.

Cerezyme Side Effects Report #5688159-X
Physician from JAPAN reported CEREZYME problem on Mar 21, 2008. Female patient, child 8 years of age, weighting 26.46 lb, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, central line infection, femur fracture, heat stroke, hepatocellular injury, muscle injury, pneumonia, staphylococcal infection, upper respiratory tract inflammation, . CEREZYME dosage: unknown. During the same period patient was treated with VALPROATE, CLONAZEPAM, FAMOTIDINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5688186-2
ERLOTINIB problem was reported by a Physician from UNITED KINGDOM on Mar 21, 2008. Female patient, 78 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: blood pressure diastolic decreased, central line infection, pericardial effusion, pleural effusion, . ERLOTINIB dosage: (100 MG, QD) , ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, OMPRAZOLE, TEICOPLANIN, TIMETNTIN, VANCOMYCIN, LIDOCAINE. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5622931-7
Physician from GERMANY reported REVLIMID problem on Jan 10, 2008. Female patient, 62 years of age, weighting 101.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, central line infection, diarrhoea, haematocrit decreased, haemoglobin decreased, haemorrhage, hypotension, idiopathic thrombocytopenic purpura, . REVLIMID dosage: 25MG, DAILY 21/28, ORAL; 15 MG, 0-1-0-0, ORAL. During the same period patient was treated with DEXAMETHASONE, BACTRIM DS, PANTOPRAZOLE, ALLOPURINOL, VFEND, EUGALAC, AVELOX. Patient was hospitalized. Patient died on 01/06/2008.

Prograf Side Effects Report #5536020-3
PROGRAF problem was reported by a Physician from UNITED STATES on Nov 25, 2007. Female patient, child 8 years of age, weighting 39.46 lb, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: atelectasis, central line infection, lung disorder, pleural effusion, . PROGRAF dosage: unknown. During the same period patient was treated with ZENAPAX, ASPIRIN, REGLAN, PREVACID, VITAMIN. Patient was hospitalized. Patient recovered.

Intralipid Side Effects Report #5517741-5
Consumer or non-health professional from UNITED STATES reported INTRALIPID problem on Nov 01, 2007. Female patient was diagnosed with parenteral nutrition and was treated with INTRALIPID. After drug was administered, patient experienced the following problems/side effects: catheter related complication, central line infection, device breakage, staphylococcal infection, . INTRALIPID dosage: unknown. Patient recovered.